Hot Features
Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company’s lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age a... Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company’s lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1801 for treating staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 for the treatment of papulopustular rosacea; and BTX 1204A for treating atopic dermatitis. The company was incorporated in 1984 and is based in Melbourne, Australia. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.002 | 10.5263157895 | 0.019 | 0.023 | 0.018 | 19742778 | 0.01997736 | DE |
| 4 | -0.001 | -4.54545454545 | 0.022 | 0.025 | 0.018 | 14718586 | 0.02063134 | DE |
| 12 | -0.019 | -47.5 | 0.04 | 0.044 | 0.018 | 21756521 | 0.0287158 | DE |
| 26 | -0.109 | -83.8461538462 | 0.13 | 0.15 | 0.018 | 17365691 | 0.04306461 | DE |
| 52 | -0.294 | -93.3333333333 | 0.315 | 0.35 | 0.018 | 13731690 | 0.08347902 | DE |
| 156 | -0.109 | -83.8461538462 | 0.13 | 0.535 | 0.018 | 8443384 | 0.19504043 | DE |
| 260 | -0.071 | -77.1739130435 | 0.092 | 0.535 | 0.018 | 5635954 | 0.18419357 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.